-
Alex Azar spent five years in charge of Eli Lilly & Co.'s U.S. operations. During his tenure, the prices for the company's insulin products more than doubled.
-
The inspector general at Health and Human Services says Medicare should have done an in-depth review of suspicious reports from hospitals to keep them from covering up problems with infections.
-
The Georgia congressman, dogged by ethics questions, will run the $1 trillion agency and is expected to help dismantle the Affordable Care Act.